Healthcare

The company announcement followed approval of the scheme by the Supreme Court of New South Wales, a step that paved the way for the deal to move toward completion. With the scheme now Effective, attention among Australian investors and market watchers turns to the …

Capital management is a recurring theme for established ASX companies, and a fresh regulatory filing from Ansell Limited (ASX:ANN) has placed the global protection-solutions group back in front of Australian investors. On 25 June 2026 the company lodged an Appendix 3C daily on-market buy-back …

Pro Medicus (ASX:PME) traded higher in the latest session, with shares moving to approximately AUD 182.30 following the announcement of a strategic agreement with Echo IQ. The stock’s movement reflects continued investor attention on its positioning within the global medical imaging software sector, particularly …

Racura Oncology Ltd (ASX:RAC) has reached an important milestone in the clinical development of its lead oncology candidate, RC220, after treating the first patient in the Phase 1 HARNESS-1 clinical trial. The study is evaluating RC220 in combination with the standard-of-care therapy osimertinib for …

Mesoblast Limited (ASX:MSB) (NASDAQ:MESO) has drawn US$50 million under a five-year non-dilutive financing facility provided by existing shareholder and director Dr. Gregory George. The company said the new funding strengthens its capital structure by replacing higher-cost short-term debt while providing additional financial flexibility to …

Memphasys Limited (ASX:MEM) shares climbed 16.67% to AUD 0.007 during the morning session on 25 June 2026 after the reproductive biotechnology company announced further progress in the commercial rollout of its Felix System in the United Kingdom. The update highlighted rapid customer engagement, commercial …

It is worth being clear from the outset that short-term share-price moves do not always reflect a lasting change in a company's prospects. They can be driven by shifting sentiment, broader sector trends, changes in risk appetite or simply renewed attention from traders. The …